Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 52, Issue 2, 2013, Pages 140-149

  Sawada, Takeshi ^a,b   Yamamoto, Eiichiro ^a   Suzuki, Hiromu ^a   Nojima, Masanori ^a   Maruyama, Reo ^a   Shioi, Yoshihiro ^c   Akasaka, Risaburo ^c   Kamimae, Seiko ^a   Harada, Taku ^a   Ashida, Masami ^a   Kai, Masahiro ^a   Adachi, Yasushi ^a   Yamamoto, Hiroyuki ^a   Imai, Kohzoh ^d   Toyota, Minoru ^a   Itoh, Fumio ^b   Sugai, Tamotsu ^c  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME 15Q; CHROMOSOME 18; CHROMOSOME 1Q; CHROMOSOME 20; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISTANT METASTASIS; DNA METHYLATION; FEMALE; GAIN OF FUNCTION MUTATION; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; LOSS OF FUNCTION MUTATION; LYMPH NODE METASTASIS; MALE; MARKER GENE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871065125     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22013     Document Type: Article

References (52)

1. Arai T, Kino I. 1989. Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine. Acta Pathol Jpn 39: 725-730.
2. Babel I, Barderas R, Díaz-Uriarte R, Martínez-Torrecuadrada JL, Sánchez-Carbayo M, Casal JI. 2009. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 8: 2382-2395.
3. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE. 2010. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 16: 790-799.
4. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP. 1995. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1: 902-909.
5. Cardoso J, Molenaar L, de Menezes RX, Rosenberg C, Morreau H, Möslein G, Fodde R, Boer JM. 2004. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res 32: e146
6. Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Ying SY. 2006. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med 231: 534-544.
7. Cheng YW, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, Barral S, Idrees K, Khan SA, Zeng Z, Rosenberg S, Notterman DA, Ott J, Paty P, Barany F. 2008. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res 14: 6005-6013.
8. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgj?rde OC, Lothe RA. 2006. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45: 31-41.
9. Dix B, Robbins P, Carrello S, House A, Iacopetta B. 1994. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 70: 585-590.
10. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, Tomlinson IP, Carter NP. 2004. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64: 4817-4825.
11. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
12. Gaasenbeek M, Howarth K, Rowan AJ, Gorman PA, Jones A, Chaplin T, Liu Y, Bicknell D, Davison EJ, Fiegler H, Carter NP, Roylance RR, Tomlinson IP. 2006. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 66: 3471-3479.
13. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR. 2007. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138.
14. Gray JW. 2003. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 4: 4-6.
15. Grady WM, Carethers J. 2008. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099.
16. Habano W, Sugai T, Nakamura S, Yoshida T. 1996. A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab Invest 74: 933-940.
17. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G. 2002. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123: 1109-1119.
18. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW. 2012. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22: 271-282.
19. Igarashi S, Suzuki H, Niinuma T, Shimizu H, Nojima M, Iwaki H, Nobuoka T, Nishida T, Miyazaki Y, Takamaru H, Yamamoto E, Yamamoto H, Tokino T, Hasegawa T, Hirata K, Imai K, Toyota M, Shinomura Y. 2010. A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clin Cancer Res 16: 5114-5123.
20. Issa JP. 2008. Colon cancer: It's CIN or CIMP. Clin Cancer Res 14: 5939-5940.
21. Japanese Society for Cancer of the Colon and Rectum. 1997. Japanese Classification of Colorectal Carcinoma. Tokyo: Kanehara, pp. 30-63.
22. Jass JR. 2007. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
23. Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH, Byun DS, Nasser S, Arango D, Shin J, Klampfer L, Augenlicht LH, Perez-Soler R, Mariadason JM. 2008. PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res 68: 1953-1961.
24. Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, Roylance RR, Carter NP, Tomlinson IP. 2005. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24: 118-129.
25. Jover R, Nguyen TP, Pérez-Carbonell L, Zapater P, Payá A, Alenda C, Rojas E, Cubiella J, Balaguer F, Morillas JD, Clofent J, Bujanda L, Reñé JM, Bessa X, Xicola RM, Nicolás-Pérez D, Castells A, Andreu M, Llor X, Boland CR, Goel A. 2011. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology 140: 1174-1181.
26. Ju HX, An B, Okamoto Y, Shinjo K, Kanemitsu Y, Komori K, Hirai T, Shimizu Y, Sano T, Sawaki A, Tajika M, Yamao K, Fujii M, Murakami H, Osada H, Ito H, Takeuchi I, Sekido Y, Kondo Y. 2011. Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis. Am J Pathol 178: 1835-1846.
27. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM. 2004. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 126: 654-659.
28. Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fiorino A, Smith EJ, Bocanegra M, Carethers JM. 2007. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology 132: 633-644.
29. Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, Beliën JA, Hoovers JM, Joenje H, Snijders PJ, Walboomers JM. 1998. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 51: 901-909.
30. Miyazaki M, Furuya T, Shiraki A, Sato T, Oga A, Sasaki K. 1999. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers. Cancer Res 59: 5283-5285.
31. Nakamura S, Goto J, Kitayama M, Kino I. 1994. Application of the crypt-isolation technique to flow-cytometric analysis of DNA content in colorectal neoplasms. Gastroenterology 106: 100-107.
32. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, Wiencke JW, Terdiman JP, Waldman FM. 2004. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25: 1345-1357.
33. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. 2006. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588.
34. Postma C, Koopman M, Buffart TE, Eijk PP, Carvalho B, Peters GJ, Ylstra B, van Krieken JH, Punt CJ, Meijer GA. 2009. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann Oncol 20: 1048-1056.
35. Poulogiannis G, Ichimura K, Hamoudi RA, Luo F, Leung SY, Yuen ST, Harrison DJ, Wyllie AH, Arends MJ. 2010. Prognostic relevance of DNA copy number changes in colorectal cancer. J Pathol 220: 338-347.
36. Pritchard CC, Grady WM. 2011. Colorectal cancer molecular biology moves into clinical practice. Gut 60: 116-129.
37. Rajagopalan H, Lengauer C. 2004. Aneuploidy and cancer. Nature 432: 338-341.
38. Ried T, Knutzen R, Steinbeck R, Blegen H, Schröck E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15: 234-245.
39. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
40. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA, Domany E. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. 2009. Proc Natl Acad Sci USA 106: 7131-7136.
41. Shen L, Catalano PJ, Benson ABIII, O'Dwyer P, Hamilton SR, Issa JP. 2007a. Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13: 6093-6098.
42. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, Issa JP. 2007b. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 104: 18654-18659.
43. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR. 2002. Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99: 9433-9438.
44. Sugai T, Habano W, Nakamura S, Uesugi N, Sasou S, Itoh C. 2000. A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique. Arch Pathol Lab Med 124: 382-386.
45. Sugai T, Habano W, Jiao YF, Suzuki M, Takagi R, Otsuka K, Higuchi T, Nakamura S. 2005. Analysis of allelic imbalances at multiple cancer-related chromosomal loci and microsatellite instability within the same tumor using a single tumor gland from colorectal carcinomas. Int J Cancer 114: 337-345.
46. Threadgill DW. 2005. Metastatic potential as a heritable trait. Nat Genet 37: 1026-1027.
47. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. 1999. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686.
48. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132.
49. Turnbull RB Jr, Kyle K, Watson FR, Spratt J. 1967. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420-427.
50. Walther A, Houlston R, Tomlinson I. 2008. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57: 941-950.
51. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
52. Yonesaka K, Zejnullahu K, Okamoto I, Satoh T, Cappuzzo F, Souglakos J, Ercan D, Rogers A, Roncalli M, Takeda M, Fujisaka Y, Philips J, Shimizu T, Maenishi O, Cho Y, Sun J, Destro A, Taira K, Takeda K, Okabe T, Swanson J, Itoh H, Takada M, Lifshits E, Okuno K, Engelman JA, Shivdasani RA, Nishio K, Fukuoka M, Varella-Garcia M, Nakagawa K, Jänne PA. 2011. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med 3: 99ra86.